The β2-Subunit of Voltage-Gated Calcium Channels Regulates Cardiomyocyte Hypertrophy

L-type voltage-gated calcium channels (LTCCs) regulate crucial physiological processes in the heart. They are composed of the Ca v α 1 pore-forming subunit and the accessory subunits Ca v β, Ca v α 2 δ, and Ca v γ. Ca v β is a cytosolic protein that regulates channel trafficking and activity, but it...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in cardiovascular medicine 2021-07, Vol.8, p.704657-704657
Hauptverfasser: Pickel, Simone, Cruz-Garcia, Yiliam, Bandleon, Sandra, Barkovits, Katalin, Heindl, Cornelia, Völker, Katharina, Abeßer, Marco, Pfeiffer, Kathy, Schaaf, Alice, Marcus, Katrin, Eder-Negrin, Petra, Kuhn, Michaela, Miranda-Laferte, Erick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:L-type voltage-gated calcium channels (LTCCs) regulate crucial physiological processes in the heart. They are composed of the Ca v α 1 pore-forming subunit and the accessory subunits Ca v β, Ca v α 2 δ, and Ca v γ. Ca v β is a cytosolic protein that regulates channel trafficking and activity, but it also exerts other LTCC-independent functions. Cardiac hypertrophy, a relevant risk factor for the development of congestive heart failure, depends on the activation of calcium-dependent pro-hypertrophic signaling cascades. Here, by using shRNA-mediated Ca v β silencing, we demonstrate that Ca v β 2 downregulation enhances α1-adrenergic receptor agonist-induced cardiomyocyte hypertrophy. We report that a pool of Ca v β 2 is targeted to the nucleus in cardiomyocytes and that the expression of this nuclear fraction decreases during in vitro and in vivo induction of cardiac hypertrophy. Moreover, the overexpression of nucleus-targeted Ca v β 2 in cardiomyocytes inhibits in vitro -induced hypertrophy. Quantitative proteomic analyses showed that Ca v β 2 knockdown leads to changes in the expression of diverse myocyte proteins, including reduction of calpastatin, an endogenous inhibitor of the calcium-dependent protease calpain. Accordingly, Ca v β 2 -downregulated cardiomyocytes had a 2-fold increase in calpain activity as compared to control cells. Furthermore, inhibition of calpain activity in Ca v β 2 -downregulated cells abolished the enhanced α1-adrenergic receptor agonist-induced hypertrophy observed in these cells. Our findings indicate that in cardiomyocytes, a nuclear pool of Ca v β 2 participates in cellular functions that are independent of LTCC activity. They also indicate that a downregulation of nuclear Ca v β 2 during cardiomyocyte hypertrophy promotes the activation of calpain-dependent hypertrophic pathways.
ISSN:2297-055X
2297-055X
DOI:10.3389/fcvm.2021.704657